… biosimilars company and subsidiary of Biocon, has announced that the Medicines … ) recently granted marketing authorisation for Biocon Biologics Denosumab biosimilars, allowing their …

… 02:57 PM New Delhi: Biocon Ltd on Monday said its … arm Biocon Biologics Ltd has received … advanced malignancies involving bone, Biocon said in a regulatory filing … increased risk of fractures. Biocon Biologics was recently granted marketing …

… Monday said its arm Biocon Biologics Ltd has received marketing … with advanced malignancies involving bone, Biocon said in a regulatory filing … at increased risk of fractures. Biocon Biologics was recently granted marketing …

… company and subsidiary of Biocon Ltd., today announced that … recently granted marketing authorisation for Biocon Biologics Denosumab biosimilars, allowing … Source : Equity Bulls Keywords Biocon INE376G01013 Biotechnology BioconBiologics UKMHRA Approval …

… biosimilars company and subsidiary of Biocon Ltd., has received marketing authorisations … ) recently granted marketing authorisation for Biocon Biologics Denosumab biosimilars, allowing their … giant cell tumour of bone Biocon Limited, publicly listed in 2004 …

… 1880| Stop Loss Rs 1800 Biocon: Buy| Target Rs 390| Stop …

… (BBL), a subsidiary of Biocon Ltd., has received marketing authorization … Area. With these regulatory wins, Biocon Biologics is solidifying its position …

… of words has erupted between Biocon founder Kiran Mazumdar-Shaw and …

… , responding to objections raised by Biocon chief Kiran Mazumdar Shaw over …

… Karnataka Chief Minister Siddaramaiah and Biocon founder Kiran Mazumdar-Shaw. Charges …